Last reviewed · How we verify
NCT07233902
MS Synchronous vs Asynchronous Exercise Study
NA trial testing Combined Exercise Program (Synchronous Delivery) in Multiple Sclerosis in 16 participants. Completed in 29 October 2025.
1 October 2025
Quick facts
| Lead sponsor | Yeditepe University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | supportive care |
| Enrollment | 16 |
| Start date | 1 April 2025 |
| Primary completion | 1 October 2025 |
| Estimated completion | 29 October 2025 |
| Sites | 1 location across Turkey (Türkiye) |
Drugs / interventions tested
- Combined Exercise Program (Synchronous Delivery)
- Combined Exercise Program (Asynchronous Delivery)
Conditions studied
- Multiple Sclerosis — all drugs for Multiple Sclerosis →
- Multiple Sclerosis (MS) - Relapsing-remitting — all drugs for Multiple Sclerosis (MS) - Relapsing-remitting →
Sponsor
Yeditepe University
Who can join
Adults 18 to 55, any sex, with Multiple Sclerosis or Multiple Sclerosis (MS) - Relapsing-remitting. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This randomized controlled study aims to compare the effects of synchronous and asynchronous exercise programs on individuals diagnosed with relapsing-remitting multiple sclerosis (RRMS). Participants meeting the inclusion criteria (EDSS score between 2 and 5.5, aged 18-55) were randomly assigned to either the Synchronous Exercise Group (SEG) or the Asynchronous Exercise Group (ASEG). The synchronous program was delivered via live online sessions using Google Meet and WhatsApp video calls, while the asynchronous program consisted of pre-recorded exercise videos accessible to participants. Both programs included structured exercises focusing on functional capacity, muscle strength, fatigue, independence, and quality of life. The sample size was determined using G\*Power software based on previous studies in individuals with multiple sclerosis, targeting a total of 16. Statistical analyses will be conducted using SPSS 26.0. Parametric and non-parametric tests will be used depending on data distribution, with significance set at p \< 0.05. The study seeks to improve accessibility to exercise programs for MS patients and provide evidence for the efficacy of remotely delivered synchronous versus asynchronous rehabilitation models.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT07233902
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Multiple Sclerosis
Currently open trials in the same condition.
- NCT07507084 — The Effect of Internal- or External-Focused Exercise Training, Administered in Conjunction With a Cognitive Task, on Wal · NA · recruiting
- NCT07524231 — Evaluation of the Effects of Laughter Yoga · NA · recruiting
- NCT07489794 — URINARY INCONTINENCE AND PELVIC FLOOR MUSCLE ACTIVITY IN MULTIPLE SCLEROSIS · recruiting
- NCT07236684 — Identification of Factors Related to UI in Patients With MS and EMG Assessment of PFM Activity · recruiting
- NCT07500727 — Skeletal Muscle Aging and Responsiveness in Aged People With MS · NA · recruiting
Other Yeditepe University trials
Trials by the same sponsor.
- NCT07515833 — Loss of Balance Experienced by Industrial Workers Due to Hearing Problems · not yet recruiting
- NCT07477535 — Thoracic Mobility, Posture, Functional Capacity, and Respiratory Rate in Children Playing Wind Instruments · not yet recruiting
- NCT07495280 — Effects of Dynamic Neuromuscular Stabilization Exercises Versus Balance Exercises in Older Adults · NA · not yet recruiting
- NCT07521150 — Physiotherapy and Rehabilitation in Melorheostosis: A Case Report · NA · not yet recruiting
- NCT07325396 — Neuromuscular Training in Professional Esports Players · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07233902 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Yeditepe University
- Last refreshed: 21 January 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07233902.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing